𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of nitric oxide synthase — potential for a novel class of therapeutic agent?

✍ Scribed by Jill E. Ogden; Philip K. Moore

Book ID
114151985
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
1020 KB
Volume
13
Category
Article
ISSN
0167-7799

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THERAPEUTIC STRATEGIES FOR THE INHIBITIO
THERAPEUTIC STRATEGIES FOR THE INHIBITION OF INDUCIBLE NITRIC OXIDE SYNTHASE—POTENTIAL FOR A NOVEL CLASS OF ANTI-INFLAMMATORY AGENTS
✍ JOSEF PFEILSCHIFTER; WOLFGANG EBERHARDT; RICHARD HUMMEL; DIETER KUNZ; HEIKO MÜHL 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 215 KB

In recent years, NO, a gas previously considered a potentially toxic chemical, has become established as a diffusible universal messenger mediating cell-cell communication throughout the body. In mammals, NO is a recognized mediator of blood vessel relaxation that helps to maintain blood pressure. I

Nitric Oxide Synthase Inhibition
Nitric Oxide Synthase Inhibition
✍ Mulrennan, Siobhan A; Redington, Anthony E 📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 136 KB
Biology and chemistry of the inhibition
Biology and chemistry of the inhibition of nitric oxide synthases by pteridine-derivatives as therapeutic agents
✍ Hans Matter; Peter Kotsonis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

## Abstract Inhibitors of the family of nitric oxide synthases (NOS‐I–III; EC 1.14.13.39) are of interest as pharmacological agents to modulate pathologically high nitric oxide (NO) levels in inflammation, sepsis, and stroke. In this article, we discuss the approach for targeting the unique (__6R__